Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 4/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 4 Months | 13 Years 5 Months | ||
Fund AUM | ₹1301 Cr | ₹8306 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.69% | 0.91% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 36 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.59% | 99.7% | ||
Debt % | - | - | ||
P/E | 41.15 | 35.73 | ||
P/B | 6.83 | 5.7 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.43% | -2.91% | ||
3-Month Return | -4.84% | -1.77% | ||
6-Month Return | -5.14% | -1.1% | ||
1-Year Return | 1.06% | 3.24% | ||
3-Year Return | 24.51% | 24.53% | ||
5-Year Return | 16.83% | 16.64% |
Sharpe | 1.13 | 1.17 | ||
Alpha | 1 | 0.22 | ||
Beta | 0.95 | 0.9 | ||
Standard Deviation | 16.16 | 15.21 | ||
Information Ratio | 0.04 | -0.47 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma |

